314 related articles for article (PubMed ID: 37120508)
1. Circulating biosignatures in multiple myeloma and their role in multidrug resistance.
Krishnan SR; Bebawy M
Mol Cancer; 2023 Apr; 22(1):79. PubMed ID: 37120508
[TBL] [Abstract][Full Text] [Related]
2. A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma.
Rajeev Krishnan S; De Rubis G; Suen H; Joshua D; Lam Kwan Y; Bebawy M
Blood Cancer J; 2020 Mar; 10(3):37. PubMed ID: 32170169
[TBL] [Abstract][Full Text] [Related]
3. Microparticle-associated nucleic acids mediate trait dominance in cancer.
Jaiswal R; Gong J; Sambasivam S; Combes V; Mathys JM; Davey R; Grau GE; Bebawy M
FASEB J; 2012 Jan; 26(1):420-9. PubMed ID: 21965597
[TBL] [Abstract][Full Text] [Related]
4. Microparticles and their emerging role in cancer multidrug resistance.
Gong J; Jaiswal R; Mathys JM; Combes V; Grau GE; Bebawy M
Cancer Treat Rev; 2012 May; 38(3):226-34. PubMed ID: 21757296
[TBL] [Abstract][Full Text] [Related]
5. Cell-derived microvesicles and antitumoral multidrug resistance.
Tatischeff I
C R Biol; 2012 Feb; 335(2):103-6. PubMed ID: 22325563
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles in Chemoresistance.
De Rubis G; Bebawy M
Subcell Biochem; 2021; 97():211-245. PubMed ID: 33779919
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in multiple myeloma.
Sonneveld P
Pathol Biol (Paris); 1999 Feb; 47(2):182-7. PubMed ID: 10192886
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells.
Lopes-Rodrigues V; Di Luca A; Sousa D; Seca H; Meleady P; Henry M; Lima RT; O'Connor R; Vasconcelos MH
Biochim Biophys Acta; 2016 Mar; 1860(3):618-27. PubMed ID: 26708992
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of multidrug resistance in oncology and hematology].
Petrini M; Galimberti S
Tumori; 1997; 83(5 Suppl):S17-20. PubMed ID: 9446254
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review).
Krishnan SR; Jaiswal R; Brown RD; Luk F; Bebawy M
Int J Oncol; 2016 Jul; 49(1):33-50. PubMed ID: 27175906
[TBL] [Abstract][Full Text] [Related]
11. Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion.
Jaiswal R; Johnson MS; Pokharel D; Krishnan SR; Bebawy M
BMC Cancer; 2017 Feb; 17(1):104. PubMed ID: 28166767
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in multiple myeloma.
Sonneveld P; Lokhorst HM; Vossebeld P
Semin Hematol; 1997 Oct; 34(4 Suppl 5):34-9. PubMed ID: 9408959
[TBL] [Abstract][Full Text] [Related]
13. Proteins Regulating Microvesicle Biogenesis and Multidrug Resistance in Cancer.
Taylor J; Bebawy M
Proteomics; 2019 Jan; 19(1-2):e1800165. PubMed ID: 30520565
[TBL] [Abstract][Full Text] [Related]
14. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
[TBL] [Abstract][Full Text] [Related]
15. Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways.
Lu JF; Luk F; Gong J; Jaiswal R; Grau GE; Bebawy M
Pharmacol Res; 2013 Oct; 76():77-83. PubMed ID: 23917219
[TBL] [Abstract][Full Text] [Related]
16. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
17. Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR.
Shain KH; Dalton WS
Mol Cancer Ther; 2001 Nov; 1(1):69-78. PubMed ID: 12467240
[TBL] [Abstract][Full Text] [Related]
18. An update on extracellular vesicles in multiple myeloma: a focus on their role in cell-to-cell cross-talk and as potential liquid biopsy biomarkers.
De Luca L; Laurenzana I; Trino S; Lamorte D; Caivano A; Musto P
Expert Rev Mol Diagn; 2019 Mar; 19(3):249-258. PubMed ID: 30782029
[TBL] [Abstract][Full Text] [Related]
19. Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.
Bouvy C; Wannez A; Laloy J; Chatelain C; Dogné JM
Leuk Res; 2017 Nov; 62():70-76. PubMed ID: 28987820
[TBL] [Abstract][Full Text] [Related]
20. Modulation of multidrug resistance (MDR) in hematological malignancies.
Covelli A
Ann Oncol; 1999; 10 Suppl 6():53-9. PubMed ID: 10676553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
